Satellos Bioscience Inc.

C$10.12As of Sun 8 Nov 2026, 12:00 UTC
TSX:MSCLHealthcare
Country Canada
PE (Fwd) •••
TSR 5Y CAGR (12.13%)
Div yield —
ROE (70.45%)
Biotechnology
Beta (5Y) 1.19
PE TTM —
TSR TTM 9.52%
Mkt cap C$214.7M
ROIC (45.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$13
29.77%
744.67%
Buy 7|7|4|5|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.25
0.26
0.26
0.25
25.53%
23.34%
20.18%
6.16%
Revenue$M
16.06
16.56
16.54
16.47
6.96%
10.03%
5.74%
3.85%
Peers (US$152.0M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
6.188
0.033
0.035
EBIT/Intx
1.419
0.214
0.215
Own earn%
(236.98)
(50.73)
(55.54)
Sh yield%
38.89
27.80
27.22
Owners
Insiders/Inst%
11.12
37.90
Short interest%
2.61
SBC / revenue%
0.47
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
0–7
$1 testx
0.0
Incr. ROIC%
9